http://convention.bio.org/2016/CEO, Michael Nelson, will present at the 2016 BIO International Convention on Tuesday, June 7 at 2pm at the New York Pavilion to discuss Intrommune’s lead product, INT-301, which is being developed for the treatment of peanut allergies.
Event: 2016 BIO International Convention
Event page: http://convention.bio.org/2016/
Press Release: https://globenewswire.com/news-release/2016/06/06/846258/0/en/Intrommune-Therapeutics-to-Present-at-2016-BIO-International-Convention.html
Location: New York Pavilion, San Francisco, CA